The global Dasatinib Drugs market is estimated to be valued at US$ 4.35 billion in 2023 and is expected to exhibit a CAGR of 6.0% over the forecast period, as highlighted in a new report published by Coherent Market Insights.Market Overview:Dasatinib is a targeted therapy for the treatment of chronic myeloid leukemia (CML) and certain types of acute lymphoblastic leukemia (ALL). It is a...